These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 13665202)

  • 1. The present controversy in the treatment of female breast carcinoma.
    ABRAMSON PD
    J La State Med Soc; 1959 Jun; 111(6):193-200. PubMed ID: 13665202
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy-related acute promyelocytic leukemia after treatment of carcinoma breast--a case report.
    Bhattacharyya M; Chatterjee T; Panigrahi I; Kannan M; Choudhry VP; Mahapatra M; Saxena R
    Indian J Pathol Microbiol; 2006 Apr; 49(2):251-4. PubMed ID: 16933728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of small cell carcinoma of the breast.
    Sadanaga N; Okada S; Shiotani S; Morita M; Kakeji Y; Kitamura K; Tamiya S; Sugimachi K; Maehara Y
    Oncol Rep; 2008 Apr; 19(4):981-5. PubMed ID: 18357385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial brachytherapy as the sole treatment for tongue metastasis from breast carcinoma.
    Hannoun-Levi JM; Largillier R; Dassonville O
    Rev Laryngol Otol Rhinol (Bord); 2006; 127(3):191-2. PubMed ID: 17007196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
    Voogd AC; Ernst MF
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):505-6; author reply 506. PubMed ID: 15042903
    [No Abstract]   [Full Text] [Related]  

  • 6. Inflammatory breast cancer: patient advocate view.
    Mason G; Johnson O
    Semin Oncol; 2008 Feb; 35(1):87-91. PubMed ID: 18308150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic approaches for breast carcinoma].
    Petrakova K; Růzicková J; Fait V
    Klin Onkol; 2008; 21(4):131-40. PubMed ID: 19102218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
    Tjalma WA
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):507; author reply 507. PubMed ID: 15042904
    [No Abstract]   [Full Text] [Related]  

  • 9. Signet ring cell carcinoma of the breast as a source of pelvic floor metastatic mass. A case report.
    Colak T; Akca T; Dirlik M; Caglikulekci M; Seyrek E; Cinel L; Bozdogan R; Aydin S
    Acta Chir Belg; 2005 Apr; 105(2):224-6. PubMed ID: 15906923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
    Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast carcinoma during pregnancy. International recommendations from an expert meeting.
    Loibl S; von Minckwitz G; Gwyn K; Ellis P; Blohmer JU; Schlegelberger B; Keller M; Harder S; Theriault RL; Crivellari D; Klingebiel T; Louwen F; Kaufmann M
    Cancer; 2006 Jan; 106(2):237-46. PubMed ID: 16342247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remembering inflammatory breast cancer. Are you up to date on management and treatment?
    Penn CL
    J Ark Med Soc; 2007 Oct; 104(4):80-2. PubMed ID: 17953196
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary small cell neuroendocrine tumour of the breast.
    Jochems L; Tjalma WA
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):231-3. PubMed ID: 15262362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic principles in breast reconstruction.
    Cho BC; McCready DR
    Clin Plast Surg; 2007 Jan; 34(1):1-13; abstract v. PubMed ID: 17307067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast-conserving therapy in breast cancer].
    Marcollet A; Doridot V; Nos C
    Rev Prat; 2004 Apr; 54(8):847-53. PubMed ID: 15274458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
    Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversy surrounding examination of sentinel lymph node in management of breast cancer.
    Forouhar F
    Cancer; 2009 Apr; 115(7):1361-2. PubMed ID: 19208425
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroendocrine tumor of the breast.
    Valdes EK; Feldman SM; Krassilnik N
    Am Surg; 2006 Feb; 72(2):185-7. PubMed ID: 16536254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Trends in the treatment of ductal carcinoma in situ of the breast.
    Zorbas H; Luxford K; Evans A; Villanueva EV
    J Natl Cancer Inst; 2004 Aug; 96(16):1258; author reply 1259-60. PubMed ID: 15316063
    [No Abstract]   [Full Text] [Related]  

  • 20. Variations in treatment of ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
    Schouten van der Velden AP; Van Dijck JA; Wobbes T
    Eur J Surg Oncol; 2007 May; 33(4):424-9. PubMed ID: 17084060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.